AIDS Prevention Gel Fails in Trial, Researchers Say
Researchers said the failure of the microbicide gels in a trial in South Africa, Zambia, Uganda and Tanzania was the last nail in the coffin for this type of prevention method.
December 15, 2009 — New York Times
A gel against HIV fails, disappointing researchers
An antimicrobial gel tested as a method to curb the spread of HIV just proved ineffective in a major human study.
December 14, 2009 — NPR
Celebrating the possible in the fight against AIDS
A decade of increasing funding for HIV programs – in prevention, treatment and research – is paying off. Ironically, though, this good news comes at the same time that the global economic crisis and political arguments threaten the future of HIV funding.
November 30, 2009 — Huffington Post
Thai HIV vaccine study: modest effect is real, argue researchers
The modest protective effect of the HIV vaccine combination used in the Thai vaccine trial announced last month is statistically significant and not the result of massaging the statistics to produce a positive result, study investigators said at the AIDS Vaccine 2009 conference in Paris today.
October 20, 2009 — aidsmap
AIDS vaccine study reassures skeptics
The fog around the largest AIDS vaccine study ever conducted began to lift today, as Thai and U.S. researchers for the first time publicly presented a detailed analysis of their data to over 1000 scientists gathered here at an annual meeting.
October 20, 2009 — Science Insider
Data Call Into Question HIV Study Results
Researchers from the U.S. Army and Thailand announced last month they had found the first vaccine that provided some protection against HIV. But a second analysis of the $105 million study, not disclosed publicly, suggests the results may have been a fluke, according to AIDS scientists who have seen it.
October 12, 2009 — Wall Street Journal
For first time, AIDS vaccine shows some success
The vaccine — known as RV 144, a combination of two genetically engineered vaccines, neither of which had worked before in humans — was declared a qualified success after a six-year clinical trial on more than 16,000 volunteers in Thailand. Those who were vaccinated became infected at a rate nearly one-third lower than the others, the sponsors said Thursday morning.
September 24, 2009 — New York Times
New Web Site Seeks to Fight Myths About Circumcision and HIV
Trying to fight misconceptions about the link between H.I.V. transmission and circumcision.
March 3, 2009 — New York Times
Indevus’ sex gel shows first AIDS protection in women
A vaginal gel made byIndevus Pharmaceuticals Inc.showed first signs that such a product might protect women from the AIDS virus.
February 9, 2009 — Bloomberg
→ Continue through the archives. Find articles from 2008.